Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 Feb;89(2):648–656. doi: 10.1172/JCI115631

Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.

U S Sajjan 1, M Corey 1, M A Karmali 1, J F Forstner 1
PMCID: PMC442898  PMID: 1371125

Abstract

Although not as prevalent as Pseudomonas aeruginosa, Pseudomonas cepacia is another opportunistic pathogen which colonizes the lungs of at least some patients with cystic fibrosis. A subgroup of these patients exhibits the "cepacia syndrome", i.e., a rapid clinical deterioration and death within one year. To investigate potential early sites of bacterial attachment, we have measured the specific binding of P. cepacia isolates from cystic fibrosis (CF) sputa to both CF and non-CF mucins purified from respiratory and intestinal secretions, respectively. As shown in microtiter binding assays, clinical isolates from 19/22 patients were found to bind to both mucins, with the highest specific binding exhibited by isolates from eight patients, seven of whom later died with the cepacia syndrome. No differences were observed in the binding capacity of the two (CF versus non-CF) mucins. Binding was specific, saturable, and not influenced by tetramethylurea, a disruptor of hydrophobic associations. Individual sugars were ineffective as hapten inhibitors, as were several lectins. Mucins treated by reduction/alkylation or chloroform/methanol extraction showed enhanced bacterial binding, findings which were attributed to exposure of underlying binding sites. Deglycosylation procedures indicated that mucin receptors for P. cepacia include N-acetylglucosamine and N-acetylgalactosamine, probably linked together as part of core oligosaccharide structures. P. cepacia isolates also bound to buccal epithelial cells, and mucin partially inhibited the binding of those isolates of P. cepacia that also had the ability to bind to mucin. We speculate that specific binding of P. cepacia to secreted mucins may be an early step in the pathogenesis of the cepacia syndrome.

Full text

PDF
648

Images in this article

653Image
on p.653
653Image
on p.653
654Image
on p.654

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baltimore R. S., Christie C. D., Smith G. J. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis. 1989 Dec;140(6):1650–1661. doi: 10.1164/ajrccm/140.6.1650. [DOI] [PubMed] [Google Scholar]
  2. Carlson D. M. Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins. J Biol Chem. 1968 Feb 10;243(3):616–626. [PubMed] [Google Scholar]
  3. Doig P., Todd T., Sastry P. A., Lee K. K., Hodges R. S., Paranchych W., Irvin R. T. Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect Immun. 1988 Jun;56(6):1641–1646. doi: 10.1128/iai.56.6.1641-1646.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ederer G. M., Matsen J. M. Colonization and infection with Pseudomonas cepacia. J Infect Dis. 1972 Jun;125(6):613–618. doi: 10.1093/infdis/125.6.613. [DOI] [PubMed] [Google Scholar]
  5. Edge A. S., Faltynek C. R., Hof L., Reichert L. E., Jr, Weber P. Deglycosylation of glycoproteins by trifluoromethanesulfonic acid. Anal Biochem. 1981 Nov 15;118(1):131–137. doi: 10.1016/0003-2697(81)90168-8. [DOI] [PubMed] [Google Scholar]
  6. Fahim R. E., Forstner G. G., Forstner J. F. Heterogeneity of rat goblet-cell mucin before and after reduction. Biochem J. 1983 Jan 1;209(1):117–124. doi: 10.1042/bj2090117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gessner A. R., Mortensen J. E. Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Med Microbiol. 1990 Oct;33(2):115–120. doi: 10.1099/00222615-33-2-115. [DOI] [PubMed] [Google Scholar]
  8. Hansson G. C., Karlsson K. A., Larson G., Strömberg N., Thurin J. Carbohydrate-specific adhesion of bacteria to thin-layer chromatograms: a rationalized approach to the study of host cell glycolipid receptors. Anal Biochem. 1985 Apr;146(1):158–163. doi: 10.1016/0003-2697(85)90410-5. [DOI] [PubMed] [Google Scholar]
  9. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. doi: 10.1016/s0022-3476(84)80993-2. [DOI] [PubMed] [Google Scholar]
  10. Krivan H. C., Ginsburg V., Roberts D. D. Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2). Arch Biochem Biophys. 1988 Jan;260(1):493–496. doi: 10.1016/0003-9861(88)90473-0. [DOI] [PubMed] [Google Scholar]
  11. Lonon M. K., Woods D. E., Straus D. C. Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol. 1988 May;26(5):979–984. doi: 10.1128/jcm.26.5.979-984.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mantle M., Forstner G. G., Forstner J. F. Biochemical characterization of the component parts of intestinal mucin from patients with cystic fibrosis. Biochem J. 1984 Dec 1;224(2):345–354. doi: 10.1042/bj2240345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sadler J. E., Rearick J. I., Paulson J. C., Hill R. L. Purification to homogeneity of a beta-galactoside alpha2 leads to 3 sialyltransferase and partial purification of an alpha-N-acetylgalactosaminide alpha2 leads to 6 sialyltransferase from porcine submaxillary glands. J Biol Chem. 1979 Jun 10;254(11):4434–4442. [PubMed] [Google Scholar]
  14. Saiman L., Cacalano G., Prince A. Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun. 1990 Aug;58(8):2578–2584. doi: 10.1128/iai.58.8.2578-2584.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sajjan U., Reisman J., Doig P., Irvin R. T., Forstner G., Forstner J. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest. 1992 Feb;89(2):657–665. doi: 10.1172/JCI115632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sanford B. A., Thomas V. L., Ramsay M. A. Binding of staphylococci to mucus in vivo and in vitro. Infect Immun. 1989 Dec;57(12):3735–3742. doi: 10.1128/iai.57.12.3735-3742.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Silvestri L. J., Hurst R. E., Simpson L., Settine J. M. Analysis of sulfate in complex carbohydrates. Anal Biochem. 1982 Jul 1;123(2):303–309. doi: 10.1016/0003-2697(82)90450-x. [DOI] [PubMed] [Google Scholar]
  18. Slomiany A., Slomiany B. L., Witas H., Aono M., Newman L. J. Isolation of fatty acids covalently bound to the gastric mucus glycoprotein of normal and cystic fibrosis patients. Biochem Biophys Res Commun. 1983 May 31;113(1):286–293. doi: 10.1016/0006-291x(83)90464-3. [DOI] [PubMed] [Google Scholar]
  19. Sobel J. D., Hashman N., Reinherz G., Merzbach D. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med. 1982 Aug;73(2):183–186. doi: 10.1016/0002-9343(82)90176-0. [DOI] [PubMed] [Google Scholar]
  20. Sorensen K., Brodbeck U. Assessment of coating-efficiency in ELISA plates by direct protein determination. J Immunol Methods. 1986 Dec 24;95(2):291–293. doi: 10.1016/0022-1759(86)90419-9. [DOI] [PubMed] [Google Scholar]
  21. Tablan O. C., Chorba T. L., Schidlow D. V., White J. W., Hardy K. A., Gilligan P. H., Morgan W. M., Carson L. A., Martone W. J., Jason J. M. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985 Sep;107(3):382–387. doi: 10.1016/s0022-3476(85)80511-4. [DOI] [PubMed] [Google Scholar]
  22. Tablan O. C., Martone W. J., Doershuk C. F., Stern R. C., Thomassen M. J., Klinger J. D., White J. W., Carson L. A., Jarvis W. R. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest. 1987 Apr;91(4):527–532. doi: 10.1378/chest.91.4.527. [DOI] [PubMed] [Google Scholar]
  23. Thomassen M. J., Demko C. A., Klinger J. D., Stern R. C. Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis. 1985 May;131(5):791–796. doi: 10.1164/arrd.1985.131.5.791. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES